(2R,3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Term ID

CHEBI:155755

Synonyms

alpha-D-gluco-hexopyranosyl-(1->6)-D-gluco-hexopyranosyl-(1->2)-beta-D-gluco-hexopyranose
Glc(a1-6)Glc(?1-2)b-Glc

Definition

References

glygen:G94135GM
glytoucan:G94135GM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype where environments contain (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype modified by environments containing (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype affecting (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Human Disease Model